Singapore markets closed

Tasly Pharmaceutical Group Co., Ltd (600535.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
12.56-0.35 (-2.71%)
At close: 03:00PM CST
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
4,450,601
3,119,352
2,303,892
1,975,893
-
Other short-term investments
300,708
1,124,963
1,487,462
142,919
-
Total cash
4,751,309
4,244,314
3,791,355
2,118,811
-
Net receivables
688,003
896,207
1,294,634
1,872,207
-
Inventory
1,747,685
1,532,089
1,547,876
1,353,741
-
Other current assets
25,854
48,998
42,706
48,318
-
Total current assets
8,732,681
9,260,211
9,249,306
9,203,507
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
7,510,513
7,265,583
7,143,918
6,903,862
-
Accumulated depreciation
-3,741,322
-3,382,382
-3,056,034
-2,733,653
-
Net property, plant and equipment
3,769,191
3,883,202
4,087,885
4,170,208
-
Goodwill
15,880
15,880
167,081
15,880
-
Intangible assets
2,026,535
1,587,405
1,625,535
1,646,411
-
Other long-term assets
43,142
102,084
79,682
8,447
-
Total non-current assets
7,981,604
7,216,703
7,292,253
7,473,035
-
Total assets
16,714,285
16,476,914
16,541,558
16,676,543
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
723,051
184,478
177,939
637,307
-
Accounts payable
572,726
887,765
728,576
684,324
-
Other current liabilities
79,665
69,581
69,787
70,530
-
Total current liabilities
2,369,556
2,147,215
1,855,054
2,901,841
-
Non-current liabilities
Long-term debt
1,414,063
1,376,214
1,034,401
1,020,018
-
Deferred tax liabilities
110.4756
22,872
42,179
22,546
-
Deferred revenues
159,025
177,791
214,570
234,556
-
Other long-term liabilities
-
-
-
472.724
3,232,026
Total non-current liabilities
1,654,720
1,652,182
1,372,783
1,390,467
-
Total liabilities
4,024,276
3,799,397
3,227,837
4,292,308
-
Stockholders' equity
Common stock
1,499,700
1,499,700
1,512,666
1,512,666
-
Retained earnings
8,291,751
7,825,514
8,798,073
7,062,833
-
Total stockholders' equity
12,368,420
12,412,395
12,981,164
11,972,467
-
Total liabilities and stockholders' equity
16,714,285
16,476,914
16,541,558
16,676,543
-